The chemotherapeutic agents nocodazole and amsacrine cause meiotic delay and non-disjunction in spermatocytes of mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 651, Issue 1-2, 2008, Pages 105-113

  Attia, Sabry M ^a,c   Badary, Osama A ^b   Hamada, Farid M ^a   Hrabé de Angelis, Martin ^c   Adler, Ilse Dore ^c  

^a Al Azhar University   (Egypt)

^b Ein Helwan   (Egypt)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Amsacrine; Aneuploidy; Mouse; Nocodazole; Sperm FISH

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; BROXURIDINE; NOCODAZOLE; SOLVENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE PROGRESSION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIPLOIDY; DOSE RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC COUNSELING; GENETIC RISK; GENOTOXICITY; MALE; MEIOSIS; MOUSE; NONDISJUNCTION; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SPERMATOCYTE; TOXICITY TESTING;

AMSACRINE; ANEUPLOIDY; ANIMALS; ANTINEOPLASTIC AGENTS; IN SITU HYBRIDIZATION, FLUORESCENCE; INJECTIONS, INTRAPERITONEAL; MALE; MEIOSIS; MICE; NOCODAZOLE; NONDISJUNCTION, GENETIC; SPERMATOCYTES;

MUS;

EID: 43049138839     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.10.011     Document Type: Article

References (72)

1. Fritz B., Hallermann C., Olert J., et al. Cytogenetic analyses of culture failures by comparative genomic hybridisation (CGH). Re-evaluation of chromosome aberration rates in early spontaneous abortions. Eur. J. Hum. Genet. 9 (2001) 539-547
2. Tempest H.G., and Griffin D.K. The relationship between male infertility and increased levels of sperm disomy. Cytogenet. Genome Res. 107 (2004) 83-94
3. Sloter E., Nath J., Eskenazi B., and Wyrobek A.J. Effects of male age on the frequencies of germinal and heritable chromosomal abnormalities in humans and rodents. Fertil. Steril. 81 (2004) 925-943
4. Hassold T., and Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat. Rev. Genet. 2 (2001) 280-291
5. Giorlandino C., Calugi G., Iaconianni L., Santoro M.L., and Lippa A. Spermatozoa with chromosomal abnormalities may result in a higher rate of recurrent abortion. Fertil. Steril. 70 (1998) 576-577
6. McInnes B., Rademaker A., Greene C.A., Ko E., Barclay L., and Martin R.H. Abnormalities for chromosomes 13 and 21 detected in spermatozoa from infertile men. Hum. Reprod. 13 (1998) 2787-2790
7. Blanco J., Gabau E., Gómez D., Baena N., Guitart M., Egozcue J., and Vidal F. Chromosome 21 disomy in the spermatozoa of the fathers of children with trisomy 21 in a population with a high prevalence of Down Syndrome: increased incidence in cases of paternal origin. Am. J. Hum. Genet. 63 (1998) 1067-1072
8. Eskenazi B., Wyrobek A.J., Kidd S.A., Lowe X., Moore II D., Weisiger K., and Aylstock M. Sperm aneuploidy in fathers of children with paternally and maternally inherited Klinefelter syndrome. Hum. Reprod. 17 (2002) 576-583
9. Brandriff B.F., Meistrich M.L., Gordon L.A., Carrano A.V., and Liang J.C. Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy. Hum. Genet. 93 (1994) 295-299
10. Robbins W.A., Meistrich M.L., Moore D., Hagemeister F.B., Weier H.U., Cassel M.J., Wilson G., Eskenazi B., and Wyrobek A.J. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat. Genet. 16 (1997) 74-78
11. Baumgartner A., Czeizel A.E., Adler I.-D., Lowe X., Schmid T.E., and Wyrobek A.J. Chromosomes X, Y, and 21 aneuploidies in sperm of men who ingested ultra-high doses of diazepam. Am. J. Hum. Genet. 59 Suppl. 1 (1996) A137
12. Baumgartner A., Schmid T.E., Schuetz C.G., and Adler I.-D. Detection of aneuploidy in rodent and human sperm by multicolor FISH after chronic exposure to diazepam. Mutat. Res. 490 (2001) 11-19
13. de Brabander M.J., van de Veire R.M., Aerts F.E., Borgers M., and Janssen P.A. The effects of methyl [5-(2-thienylcarbonyl)-1H-benzimidazole-2yl] carbamate (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res. 36 (1976) 905-916
14. Shah J.V., and Cleveland D.W. Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 103 (2000) 997-1000
15. Woods C.M., Zhu J., McQueney P.A., Bollag D., and Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1 (1995) 506-526
16. Torres K., and Horwitz S.B. Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res. 58 (1998) 3620-3626
17. Notterman D., Young S., Wainger B., and Levine A.J. Prevention of mammalian DNA reduplication following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity. Oncogene 17 (1998) 2743-2751
18. Stewart Z.A., Mays D., and Pietenpol J.A. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Res. 59 (1999) 3831-3837
19. Vidal A., and Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 247 (2000) 1-15
20. Elhajouji A., Cunha M., and Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleated mononucleates in the cytokinesis-block assay. Mutagenesis 13 (1998) 193-198
21. Elhajouji A., Tibaldi F., and Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12 (1997) 133-140
22. Decordier I., Dillen L., Cundari E., and Kirsch-Volders M. Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis 17 (2002) 337-344
23. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., and Decordier I. Indirect mechanisms of genotoxicity. Toxicol. Lett. 140-141 (2003) 63-74
24. Eichenlaub-Ritter U., and Boll I. Nocodazole sensitivity, age-related aneuploidy, and alterations in the cell cycle during maturation of mouse oocytes. Cytogenet. Cell Genet. 52 (1989) 170-176
25. Sun F., Betzendahl I., Pacchierotti F., Ranaldi R., Smitz J., Cortvrindt R., and Eichenlaub-Ritter U. Aneuploidy in mouse metaphase II oocytes exposed in vivo and in vitro in preantral follicle culture to nocodazole. Mutagenesis 20 (2005) 65-73
26. Generoso W.M., Katoh M., Cain K.T., Hughes L.A., Foxworth L.B., Mitchell T.J., and Bishop J.B. Chromosome malsegregation and embryonic lethality induced by treatment of normally ovulated mouse oocytes with nocodazole. Mutat. Res. 210 (1989) 313-322
27. Everett C.A., and Searle J.B. Pattern and frequency of nocodazole induced meiotic nondisjunction in oocytes of mice carrying the 'tobacco mouse' metacentric Rb(16.17)7Bnr. Genet. Res. 66 (1995) 35-43
28. Vanderkerken K., Vanparys P., Verschaeve L., and Kirsch-Volders M. The mouse bone marrow micronucleus assay can be used to distinguish aneugens from clastogens. Mutagenesis 4 (1989) 6-11
29. Tinwell H., and Ashby J. Micronucleus morphology as a means to distinguish aneugens and clastogens in the mouse bone marrow micronucleus assay. Mutagenesis 6 (1991) 193-198
30. Miller L.P., Pyesmany A.F., Wolff L.J., Rogers P.C., Siegel S.E., Wells R.J., Buckley J.D., and Hammond G.D. Successful reinduction therapy with amsacrine and cyclocytidine in acute nonlymphoblastic leukemia in children. A report from the Childrens' Cancer Study Group. Cancer 67 (1991) 2235-2240
31. Errington F., Willmore E., Tilby M.J., Li L., Li G., Li W., Baguley B.C., and Austin C.A. Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation. Mol. Pharmacol. 56 (1999) 1309-1316
32. Wong A., Huang C.H., and Crooke S.T. Deoxyribonucleic acid breaks produced by 4′-(9-acridinylamino)methanesulfon-m-anisidide and copper. Biochemistry 23 (1984) 2939-2945
33. Blasiak J., Gloc E., Drzewoski J., Wozniak K., Zadrozny M., Skorski T., and Pertynski T. Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat. Res. 535 (2003) 25-34
34. Boos G., and Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol. Lett. 116 (2000) 7-16
35. Ferguson L.R., Whiteside G., Holdaway K.M., and Baguley B.C. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine. Environ. Mol. Mutagen. 27 (1996) 255-262
36. Mosesso P., Darroudi F., van den Berg M., Vermeulen S., Palitti F., and Natarajan A.T. Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP16, using conventional Giemsa staining and chromosome painting techniques. Mutagenesis 13 (1998) 39-43
37. Sumner A.T. Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells. Exp. Cell Res. 217 (1995) 440-447
38. Baker L.C., Allen J.W., Harrington-Brock K., Campbell J.A., DeMarini D.M., Doerr C.L., Howard D.R., Kligerman A.D., and Moore M.M. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro. Mutagenesis 5 (1990) 541-547
39. Holmström M., and Winters V. Micronucleus induction by camptothecin and amsacrine in bone marrow of male and female CD-1 mice. Mutagenesis 7 (1992) 189-193
40. Larripa I., Mudry de Pargament M., Labal de Vinuesa M., Demattei A., and Brieux de Salum S. In vivo and in vitro cytogenetic effects of the anti-tumor agent amsacrina (AMSA). Mutat. Res. 138 (1984) 87-91
41. Robbins W.A. Cytogenetic damage measured in human sperm following cancer chemotherapy. Mutat. Res. 355 (1996) 235-252
42. de Stoppelaar J.M., van de Kuil T., Bedaf M., Verharen H.W., Slob W., Mohn G.R., Hoebee B., and van Benthem J. Increased frequencies of diploid sperm detected by multicolor FISH after treatment of rats with carbendazim without micronucleus induction in peripheral blood erythrocytes. Mutagenesis 14 (1999) 621-632
43. Schmid T.E., Xu W., and Adler I.-D. Detection of aneuploidy by multicolor FISH in mouse sperm after in vivo treatment with acrylamide, colchicine, diazepam or thiabendazole. Mutagenesis 14 (1999) 173-179
44. Schmid T.E., Attia S., Baumgartner A., Nuesse M., and Adler I.-D. Effect of chemicals on the duration of male meiosis in mice detected with laser scanning cytometry. Mutagenesis 16 (2001) 339-343
45. Ott L. An Introduction to Statistical Methods and Data Analysis. 5th ed. (1988), PWS-Kent Publishing Co., Boston pp. 120-216
46. da Cunha M.F., Meistrich M.L., and Finch-Neimeyer M.V. Effects of AMSA, an antineoplastic agent, on spermatogenesis in the mouse. J. Androl. 6 (1985) 225-229
47. Attia S.M., Schmid T.E., Badary O.A., Hamada F.M., and Adler I.-D. Molecular cytogenetic analysis in mouse sperm of chemically induced aneuploidy: studies with topoisomerase II inhibitors. Mutat. Res. 520 (2002) 1-13
48. Sachs L. Angewante Statistik. 6th ed. (1984), Springer, Berlin pp. 230-238
49. Oakberg E.F. Duration of spermatogenesis in the mouse and timing of the stages of the cycle of the seminiferous epithelium. Am. J. Anat. 99 (1956) 507-516
50. Brunet S., Pahlavan G., Taylor S., and Maro B. Functionality of the spindle checkpoint during the first meiotic division of mammalian oocytes. Reproduction 126 (2003) 443-450
51. Wassmann K., Niault T., Maro B., and Metaphase. I arrest upon activation of the MAD2-dependent spindle checkpoint in mouse oocytes. Curr. Biol. 13 (2003) 1596-1608
52. T. Ruthsatz, Molekularzytogenetische Untersuchungen in der Spermatogenese der Maus zur Erkennung von Aneuploidie-Induktion durch Chemikalien. Dissertation. Ludwig-Maximilians-Universität, München, July 2003.
53. Adler I.-D., Baumgartner A., and Schmid T.E. Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base. Mutat. Res. 504 (2002) 173-182
54. Haldane A., Holdaway K.M., Finlay G.J., and Baguley B.C. Cytokinetic differences in the action of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin. Cancer Chemother. Pharmacol. 32 (1993) 463-470
55. Kung A.L., Sherwood S.W., and Schimke R.T. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9553-9557
56. Di Leonardo A., Khan S.H., Linke S.P., Greco V., Seidita G., and Wahl G.M. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57 (1997) 1013-1019
57. Hartwell L.H., and Kastan M.B. Cell cycle control and cancer. Science 266 (1994) 1821-1828
58. Shi Q., Schmid T.E., and Adler I.-D. Griseofulvine-induced aneuploidy and meiotic delay in male mouse germ cells: detected by conventional cytogenetics and three-color FISH. Mutat. Res. 441 (1999) 180-190
59. Osheroff N. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Biochemistry 28 (1989) 6157-6160
60. Mailhes J.B., Marchetti F., Phillips Jr. G.L., and Barnhill D.R. Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposide. Teratog. Carcinog. Mutagen. 14 (1994) 39-51
61. Mailhes J.B., Marchetti F., Young D., and London S.N. Numerical and structural chromosome aberrations induced by etoposide (VP16) during oocyte maturation of mice: transmission to one-cell zygotes and damage to dictyate oocytes. Mutagenesis 11 (1996) 357-361
62. Tateno H., and Kamiguchi Y. Meiotic stage-dependent induction of chromosome aberrations in Chinese hamster primary oocytes exposed to topoisomerase II inhibitor etoposide. Mutat. Res. 476 (2001) 139-148
63. Kallio M., and Lähdetie J. Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide. Mutagenesis 11 (1996) 435-443
64. Marchetti F., Bishop J.B., Lowe X., Generoso W.M., Hozier J., and Wyrobek A.J. Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3952-3957
65. Kulling S.E., and Metzler M. Induction of micronuclei, DNA strand breaks and HPRT mutations in cultured Chinese hamster V79 cells by the phytoestrogen coumoestrol. Food Chem. Toxicol. 35 (1997) 605-613
66. Kulling S.E., Rosenberg B., Jacobs E., and Metzler M. The phytoestrogens coumoestrol and genistein induce structural chromosomal aberrations in cultured human peripheral blood lymphocytes. Arch. Toxicol. 73 (1999) 50-54
67. Tsutsui T., Tamura Y., Yagi E., Someya H., Hori I., Metzler M., and Barrett J.C. Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. Int. J. Cancer 312 (2003) 312-320
68. Stoll B.A. Eating to beat breast cancer: potential role for soy supplements. Ann. Oncol. 8 (1997) 223-225
69. Adler I.-D. Comparison of the duration of spermatogenesis between male rodents and humans. Mutat. Res. 352 (1996) 169-172
70. A. Baumgartner, Molekularzytogenetische Untersuchungen von Spermaproben des Menschen zum Nachweis von Aneuploidie-Induktion: Ein Vergleich zu experimentellen Daten bei der Maus. Dissertation. Ludwig-Maximilians-Universität, München, March 1999.
71. Paccherotti F., Ranaldi R., Eichenlaub-Ritter U., Attia S., and Adler I.-D. Evaluation of aneugenic effects of bisphenol A in somatic and germ cells of the mouse. Mutat. Res. 651 (2008) 64-70
72. Attia S.M., Badary O.A., Hamada F.M., Hrabé de Angelis M., and Adler I.-D. Othovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level. Mutat. Res. 583 (2005) 158-167